Literature DB >> 7139606

Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNA.

D J Herrick, P P Major, D W Kufe.   

Abstract

We have demonstrated recently that 5-fluorouracil (FUra) residues incorporate in eukaryotic DNA. In the present study, we extend these findings and monitor the effect of methotrexate on the formation of FUra DNA. The results demonstrate that methotrexate treatment has little effect on the incorporation of FUra or 5-fluorodeoxyuridine in DNA obtained from MCF-7 human breast carcinoma cells. More importantly, we demonstrate that FUra residues are excised from MCF-7 DNA and that methotrexate enhances the excision process. This excision of FUra from eukaryotic DNA may contribute to the cytotoxicity and mutagenicity of these fluorinated pyrimidines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139606

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  5-Fluorodeoxyuridine as an alternative to the synthesis of mixed hybridization probes for the detection of specific gene sequences.

Authors:  J F Habener; C D Vo; D B Le; G P Gryan; L Ercolani; A H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).

Authors:  Patricia M LoRusso; Sucharu Prakash; Antoinette Wozniak; Lawrence Flaherty; Mark Zalupski; Anthony Shields; Howard Sands; Ralph Parchment; Bhaskara Jasti
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

3.  The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.

Authors:  B Vandamme; I Liebaers; L Hens; J L Bernheim; C Roobol
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

Review 4.  The occurrence order and cross-talk of different tRNA modifications.

Authors:  Jing Li; Wen-Yu Zhu; Wen-Qing Yang; Cai-Tao Li; Ru-Juan Liu
Journal:  Sci China Life Sci       Date:  2021-04-19       Impact factor: 6.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.